Company Filing History:
Years Active: 2006
Title: Christopher J Herbstritt: Innovator in Antiangiogenic Agents
Introduction
Christopher J Herbstritt is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of medicine, particularly in the development of antiangiogenic agents. His work focuses on treating diseases characterized by undesirable angiogenesis, which is the formation of new blood vessels.
Latest Patents
Christopher J Herbstritt holds 1 patent for his invention titled "Antiangiogenic agents - Compositions and methods for treating mammalian disease characterized by undesirable angiogenesis by administering derivatives of 2-methoxyestradiol of the general formula: wherein the variables are defined in the specification." This patent highlights his innovative approach to addressing critical health issues.
Career Highlights
Herbstritt is associated with Entremed, Inc., a company dedicated to advancing cancer therapies. His role at the company has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Throughout his career, Christopher has collaborated with esteemed colleagues such as Gregory E Agoston and Jamshed H Shah. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Christopher J Herbstritt's work in antiangiogenic agents exemplifies the impact of innovation in medicine. His contributions continue to pave the way for advancements in treating diseases associated with angiogenesis.